Lv1
40 积分 2024-11-25 加入
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study
1天前
待确认
HER2-low breast cancer could be associated with an increased risk of brain metastasis
1天前
已完结
Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors
8个月前
已完结
皖公网安备34019202002308
